Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Aon Hewitt recommends 4% renewal for Blue Shield; board endorses buy‑down method but delays final rate approval
Summary
Aon Hewitt presented a 4% renewal for Blue Shield’s 2015 flex‑funded HMO; the board conceptually endorsed using stabilization funds to 'buy down' visible premium increases but deferred final rate approval until June to incorporate labor negotiation outcomes.
The HSS board heard a full actuarial review from Aon Hewitt, which recommended a 4% renewal for the Blue Shield flex‑funded HMO for plan year 2015 and explained the drivers behind the number, including claims trends, increases in capitations and drug costs, and applicable taxes.
Actuary Anil Kosher said the 4% reflects anticipated paid and incurred claims and noted the planned $1,000,000…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
